As reduced CD18 expression levels have also been identified on leukocytes in psoriasis patients [72,75,76,77], CD18hypo mice constitute an appropriate tool to investigate psoriatic skin disease in the context of attenuated CD18 expression as well as the role of CD18 in chronic inflammatory processes. Here, ITGB2 is linked to psoriasis.